Updates on the Renin-Angiotensin-Aldosterone System and the Cardiovascular Continuum

被引：1

作者：

Pop, Dana ^{[1
,2
]}

Dadarlat-Pop, Alexandra ^{[1
,3
]}

Tomoaia, Raluca ^{[1
,2
]}

Zdrenghea, Dumitru ^{[1
]}

Caloian, Bogdan ^{[1
,2
]}

机构：

[1] Iuliu Hatieganu Univ Med & Pharm, Fac Med, Dept Internal Med 4, Cluj Napoca 400347, Romania

[2] Rehabil Hosp, Cardiol Dept, Cluj Napoca 400012, Romania

[3] Heart Inst N Stancioiu, Cardiol Dept, Cluj Napoca 400001, Romania

来源：

BIOMEDICINES | 2024年 / 12卷 / 07期

关键词：

renin-angiotensin-aldosterone system; cardiovascular risk factors; stroke; heart failure; atrial fibrillation; CONVERTING-ENZYME-INHIBITORS; LEFT-VENTRICULAR DYSFUNCTION; CORONARY-ARTERY-DISEASE; HIGH-RISK PATIENTS; HEART-FAILURE; ATRIAL-FIBRILLATION; MYOCARDIAL-INFARCTION; RECEPTOR; THERAPY; PERINDOPRIL;

D O I：

10.3390/biomedicines12071582

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The cardiovascular continuum describes how several cardiovascular risk factors contribute to the development of atherothrombosis, ischemic heart disease, and peripheral arteriopathy, leading to cardiac and renal failure and ultimately death. Due to its multiple valences, the renin-angiotensin-aldosterone system plays an important role in all stages of the cardiovascular continuum, starting from a cluster of cardiovascular risk factors, and continuing with the development of atherosclerosis thorough various mechanisms, and culminating with heart failure. Therefore, this article aims to analyze how certain components of the renin-angiotensin-aldosterone system (converting enzymes, angiotensin, angiotensin receptors, and aldosterone) are involved in the underlying pathophysiology of the cardiovascular continuum and the possible arrest of its progression.

引用

页数：12

共 50 条

[1] The cardiovascular continuum and renin-angiotensin-aldosterone system blockade
Dzau, V
JOURNAL OF HYPERTENSION, 2005, 23 : S9 - S17
[2] Renin-angiotensin-aldosterone system inhibition and cardiovascular protection
Oguz, Aytekin
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2009, 37 : 4 - 12
[3] The renin-angiotensin-aldosterone system
Malbos, Damien
Desmouliere, Alexis
Faure, Sebastien
ACTUALITES PHARMACEUTIQUES, 2022, 61 (619): : 43 - 47
[4] RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
VALLOTTO.MB
SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1970, 100 (40) : 1666 - &
[5] RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
HERPIN, D
POUGETABADIE, JF
SUDRE, Y
DEMANGE, J
OUEST MEDICAL, 1978, 31 (11): : 727 - 738
[6] IS THERE A RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
MULLER, J
SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1972, 102 (32) : 1105 - +
[7] RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
DILLON, MJ
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 18 (01) : 105 - 108
[8] Genotypes of the renin-angiotensin-aldosterone system: on the search of cardiovascular diseases
Jalil, JE
Ocaranza, MP
REVISTA ESPANOLA DE CARDIOLOGIA, 2002, 55 (02): : 89 - 91
[9] Reducing cardiovascular risk by blockade of the renin-angiotensin-aldosterone system
Cohn, Jay N.
ADVANCES IN THERAPY, 2007, 24 (06) : 1290 - 1304
[10] Reducing cardiovascular risk by blockade of the renin-angiotensin-aldosterone system
Jay N. Cohn
Advances in Therapy, 2007, 24 : 1290 - 1304

← 1 2 3 4 5 →